HSBC Downgrades IQVIA (NYSE:IQV) to Hold
HSBC cut shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a hold rating in a research note released on Friday, MarketBeat Ratings reports. HSBC currently has $160.00 target price on the medical research company’s stock, down from their prior target price of $260.00. Several other research analysts also recently commented on […]
HSBC cut shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a hold rating in a research note released on Friday, MarketBeat Ratings reports. HSBC currently has $160.00 target price on the medical research company’s stock, down from their prior target price of $260.00. Several other research analysts also recently commented on […]
